Agios Pharmaceuticals: 4Q Earnings Snapshot
CAMBRIDGE, Mass. (AP) _ Agios Pharmaceuticals Inc. (AGIO) on Thursday reported a loss of $91.8 million in its fourth quarter.
The Cambridge, Massachusetts-based company said it had a loss of $1.58 per share.
The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of $1.65 per share.
The biopharmaceutical company posted revenue of $30 million in the period, also surpassing Street forecasts. Five analysts surveyed by Zacks expected $21 million.
For the year, the company reported that its loss widened to $346 million, or $6.03 per share. Revenue was reported as $94.4 million.
Agios Pharmaceuticals shares have increased 17 percent since the beginning of the year. The stock has declined 29 percent in the last 12 months.